About Gynaekologicum Bremen
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AGO Research GmbH
1
AGO Study Group
1
Arcagy Research
1
Canadian Cancer Trials Group
1
Clinical Trials at Gynaekologicum Bremen
During the past decade, Gynaekologicum Bremen conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma
2011-10-01
2015-11-01
Completed
47
Radical Versus Simple Hysterectomy and Pelvic Node Dissection With Low-risk Early Stage Cervical Cancer
2012-08-02
2023-12-31
Active, not recruiting
700
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Gynaekologicum Bremen"
#1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 3 trials as a collaborator, "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologishe Onkologie Germany" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were
collaborators in the rest 23 trials.
Clinical Trials Conditions at Gynaekologicum Bremen
According to Clinical.Site data, the most researched conditions in "Gynaekologicum Bremen" are
"Cervical Cancer" (1 trials), "Endometrial Neoplasms" (1 trials), "Genital Diseases, Female" (1 trials), "Ovarian Cancer" (1 trials) and "Ovarian Diseases" (1 trials). Many other conditions were trialed in "Gynaekologicum Bremen" in a lesser frequency.
Clinical Trials Intervention Types at Gynaekologicum Bremen
Most popular intervention types in "Gynaekologicum Bremen" are "Drug" (3 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Olaparib" (1 trials), "PLD" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Gynaekologicum Bremen
The vast majority of trials in "Gynaekologicum Bremen" are
4 trials for "Female" genders.
Clinical Trials Status at Gynaekologicum Bremen
Currently, there are NaN active trials in "Gynaekologicum Bremen".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Gynaekologicum Bremen,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Gynaekologicum Bremen, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".